AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 165 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 17 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 17 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 17 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |